Corrigendum to Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant, [Eur J Haematol, 91, (2013), 129-134] doi: 10.1111/ejh.12149;Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant

European Journal of Haematology

Volumn 91, Issue 2, 2013, Pages 129-134

  Pilar, Fraile ^a   Lourdes, Vazquez ^a   Dolores, Caballero ^a   Pedro, Garcia Cosmes ^a   Lucia, López ^a   Jesus, San Miguel ^a   Jose Matias, Tabernero ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Acute graft versus host disease; Allogenic hematopoietic stem cell transplant; Chronic graft versus host disease; Immunosuppression; Nephrotic syndrome

Indexed keywords

CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; RAPAMYCIN; TACROLIMUS;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEINURIA;

EID: 84880259579     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12195     Document Type: Erratum

References (18)

1. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 2009;341:14-21.
2. Chang A, Hingorani S, Kowalewska J, Flowers ME, Aneja T, Smith KD, Meehan SM, Nicosia RF, Alpers CE. Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007;2:1014-23.
3. Wang HH, Yang AH, Yang LY, Hung GY, Chang JW, Wang CK, Lee TY, Tang RB. Chronic graft-versus-host disease complicated by nephrotic syndrome. J Chin Med Assoc 2011;74:419-22.
4. Pérez-Simón JA, Encinas C, Silva F, et al. Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy. Biol Blood Marrow Transplant 2008;14:1163-71.
5. Atkinson K, Horowitz MM, Gale RP, et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989;4:247-54.
6. Terrier B, Delmas Y, Hummel A, et al. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant 2007;22:1369-76.
7. Stylianou K, Stratakis S, Mavroeidi V, et al. Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report. J Med Case Rep 2010;4:303.
8. Silva S, Maximino J, Henrique R, Paiva A, Baldaia J, Campilho F, Pimentel P, Loureiro A. Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review. J Med Case Rep 2007;1:121.
9. Heras M, Saiz A, Sánchez R, Fernandez-Reyes MJ, Mampaso F, Queizán JA, Molina A, Vázquez L, Alvarez-Ude F. Nephrotic syndrome resulting from focal segmental glomerulosclerosis in a peripheral blood stem cell transplant patient. J Nephrol 2007;20:495-8.
10. Abboud I, Peraldi MN, Hingorani S. Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines. Semin Hematol 2012;49:73-82.
11. Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 2006;1:685-94.
12. Luo XD, Liu QF, Zhang Y, et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis. Blood Cells Mol Dis 2011;46:182-7.
13. Flowers ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117:3214-9.
14. Seconi J, Watt V, Ritchie DS. Nephrotic syndrome following allogenic stem cell transplantation associated with increase production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 2003;32:447-50.
15. Ikee R, Yamamoto K, Kushiyama T, Imakiire T, Suzuki S, Miura S. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant 2004;34:1005-6.
16. Kemper MJ, Güngör T, Halter J, Schanz U, Neuhaus TJ. Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation. Clin Nephrol 2007;67:5-11.
17. Nakamura R, Palmer JM, O'Donnell MR, et al. Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. Leuk Res 2012;36:1152-6.
18. Shin HJ, Baker J, Leveson-Gower DB, Smith AT, Sega EI, Negrin RS. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+ CD25+ Foxp3+ regulatory T cells. Blood 2011;118:2342-50.